Thus, longevity medicine does not accurately differentiate the old from new therapeutic modalities.
Its purpose is to serve the needs and interests of medical practitioners whose practices include some aspect of longevity medicine.
On the other hand, longevity medicine is not sufficiently descriptive to differentiate it from the traditional approach of treating disease.
Accordingly, in contrast to "anti-aging", a more proper description of efforts to sustain health and vitality beyond maturity would be "anti-senescence" or "longevity medicine".
In recognition of the value of clinical data and the relevance of such information to the needs of longevity medicine practitioners, the journal's format will include observations, case reports, new techniques, subjective conclusions and opinions, letters, and relevant articles.
An example of such molecules is growth hormone releasing factor 1 29 NH2-acetate, or sermorelin, that recently became available to practitioners for use in longevity medicine (Merriam et al 2001).
